Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
The medical research council P...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
The medical research council PT1 trial in essential thrombocythemia.
Bibliographic Details
Main Authors:
Green, A
,
Campbell, P
,
Buck, G
,
Wheatley, K
,
East, C
,
Bareford, D
,
Wilkins, B
,
Van der Walt, J
,
Reilly, J
,
Harrison, C
Format:
Conference item
Published:
2004
Holdings
Description
Similar Items
Staff View
Similar Items
Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia.
by: Harrison, C, et al.
Published: (2005)
Reticulin accumulation in essential thrombocythemia: prognostic significance and relationship to therapy.
by: Campbell, P, et al.
Published: (2009)
Bone marrow pathology in essential thrombocythemia: interobserver reliability and utility for identifying disease subtypes.
by: Wilkins, B, et al.
Published: (2008)
Clinical significance of MPL mutations in essential thrombocythemia: Analysis of the PT-1 cohort.
by: Beer, P, et al.
Published: (2007)
Bone Marrow Fibrosis and Diagnosis of Essential Thrombocythemia Reply to J. Thiele et al
by: Campbell, P, et al.
Published: (2009)